|
Market Closed -
Euronext Paris
11:55:00 2026-08-12 EDT
|
5-day change | 1st Jan Change | ||
| 0.7310 EUR | -5.19% |
|
+12.81% | -52.41% |
| Market Cap | 58.49M 67.42M 54.84M 49.95M 93.97M 6.43B 95.45M 646M 252M 3.22B 253M 248M 10.75B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 58.49M 67.42M 54.84M 49.95M 93.97M 6.43B 95.45M 646M 252M 3.22B 253M 248M 10.75B | EV / Sales 2026 * |
48.7x | EV / Sales 2027 * | 45x |
| Free-Float |
63.24% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: AB Science
| 1 day | -5.19% | ||
| 1 week | +12.81% | ||
| Current month | +35.12% | ||
| 1 month | -0.27% | ||
| 3 months | -25.41% | ||
| 6 months | -45.45% | ||
| Current year | -52.41% |
| 1 week | 0.73 |  | 1 |
| 1 month | 0.5 | | 1 |
| Current year | 0.5 | | 1.61 |
| 1 year | 0.5 | | 1.68 |
| 3 years | 0.5 | | 4.46 |
| 5 years | 0.5 | | 14.65 |
| 10 years | 0.5 | | 21.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2026-07-06 | |
Laurent Guy
DFI | Director of Finance/CFO | - | 2009-11-19 |
| Chief Tech/Sci/R&D Officer | - | 2018-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Alain Moussy
CHM | Chairman | - | 2001-07-10 |
Patrick Moussy
BRD | Director/Board Member | - | 2011-09-19 |
| Director/Board Member | 64 | 2021-06-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 2/9/21 | Sell | Founder | 14,525 | 0.0315% | ||
| 2/2/21 | Sell | Founder | 76,104 | 0.1652% | ||
| 2/2/21 | Sell | Founder | 12,904 | 0.0280% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.19% | +12.81% | -45.04% | -77.12% | 71.19M | |
| +1.92% | +3.84% | +66.09% | +23.72% | 322B | |
| 0.00% | -4.34% | +29.63% | -14.27% | 70.24B | |
| -0.81% | +22.30% | +61.85% | +132.66% | 11.65B | |
| +1.15% | +5.71% | -2.63% | -2.85% | 8.42B | |
| -2.54% | +10.53% | -10.73% | -6.86% | 5.02B | |
| -2.92% | +11.10% | -25.80% | +15.26% | 4.52B | |
| -0.76% | +16.23% | +0.01% | +48.08% | 4.25B | |
| +2.11% | +10.68% | +17.99% | +50.11% | 2.72B | |
| -2.00% | -0.33% | -2.04% | -1.14% | 2.28B | |
| Average | -1.01% | +7.59% | +8.93% | +16.76% | 43.09B | |
| Weighted average by Cap. | +0.56% | +1.68% | +55.50% | +19.76% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.2M 1.38M 1.13M 1.02M 1.93M 132M 1.96M 13.25M 5.16M 66.15M 5.19M 5.08M 220M | 1.3M 1.5M 1.22M 1.11M 2.09M 143M 2.12M 14.36M 5.59M 71.66M 5.62M 5.5M 239M |
| Net income | - | - |
| Net Debt | - | - |
Employees
31
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-12 | €0.7310 | -5.19% | 589,361 |
| 26-08-11 | €0.7710 | +3.35% | 1,504,496 |
| 26-08-10 | €0.7460 | -25.40% | 2,914,127 |
| 26-08-07 | €1.000 | +24.07% | 1,075,191 |
| 26-08-06 | €0.8060 | +14.81% | 2,311,272 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AB Stock
Select your edition
All financial news and data tailored to specific country editions
